Edwards Lifesciences Corporation Financial Ratios — EWL

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	17.89	20.69	25.74	43.42	21.08	22.24	20.94	23.69	28.73	18.88	28.88	26.14	22.52	50.15	10.56
Return on Assets (%)	12.63	13.87	15.78	26.03	13.06	13.3	11.47	13.14	17.73	12	19.1	18.12	15.89	37.24	8.03
Return on Capital (%)	16.86	18.68	20.84	33.42	17.27	17.87	16.05	19.43	24.89	16.59	25.76	23.63	20.44	46.21	10.04
Return on Invested Capital (%)	16.08	18.1	20.26	32.85	16.91	17.53	16.17	17.92	23.61	15.73	25	19.78	16.52	13.35	9.35
Gross Margin (%)	70.82	74.15	74.74	73.07	75.25	73.09	74.52	74.77	74.37	75.36	76.13	83.79	80.47	79.46	78.01
EBITDA Margin (%)	20.05	23.33	28.38	52.94	28.13	27.75	34.1	22.18	28.43	22.91	34.88	36.69	29.02	28.2	23.42
Operating Margin (%)	17.88	22.1	23.1	20.78	25.78	26.48	29.57	28.81	28.49	30.02	30.33	34.48	29.66	27.21	26.97
Incremental Operating Margin (%)	6.82	54.21	36.05	3.64	93.85	30.21	48.98	19.76	26.55	203.39	31.93	6.21	- -	- -	24.85
Pretax Margin (%)	16.9	20.44	24.99	49.25	24.96	24.9	30.13	20.45	26.83	20.9	32.53	34.04	27.39	28.46	20.98
Profit Margin (%)	14.1	15.35	19.02	34.92	19.85	19.22	16.99	19.4	24.08	18.77	28.73	34.09	27.99	76.75	17.69
Net Income to Common Margin (%)	14.1	15.35	19.02	34.92	19.85	19.22	16.99	19.4	24.08	18.77	28.73	34.09	27.99	76.75	17.69
Effective Tax Rate (%)	16.54	24.91	23.88	29.1	20.49	22.82	43.61	5.15	10.25	10.18	11.69	12.87	11.1	9.82	17.04
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	17.89	20.69	25.74	43.42	21.08	22.24	20.94	23.69	28.73	18.88	28.88	26.14	22.52	50.15	10.56

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	150	189	593	598	597	822	1,036	594	679	695	690	691	685	700	705
ST Debt	- -	- -	- -	- -	- -	- -	598	- -	26	27	26	26	23	23	25
LT Debt	150	189	593	598	597	822	438	594	653	668	665	666	662	677	681
Total Debt/EBITDA	0.45	0.43	1.02	0.49	0.85	1	0.88	0.72	0.55	0.69	0.38	0.42	0.47	0.46	0.5
Net Debt/EBITDA	-0.06	-0.27	0.3	-0.05	-0.17	-0.13	0.19	-0.15	-0.47	-0.59	-0.15	-0.11	-0.37	-1.6	-1.65
Total Debt/EBIT	0.54	0.49	1.15	0.52	0.94	1.09	0.95	0.79	0.59	0.77	0.41	0.46	0.52	0.51	0.56
Net Debt/EBIT	-0.07	-0.31	0.33	-0.05	-0.19	-0.14	0.2	-0.16	-0.51	-0.66	-0.16	-0.12	-0.41	-1.78	-1.85
EBITDA to Interest Expense	108.55	100.73	59.24	71.5	40.78	42.83	50.49	27.61	59.71	63.59	99.19	85.31	82.6	77.47	69.65
EBITDA-CapEx/Interest Expense	106.06	99.14	59.13	70.87	40.56	40.68	50.17	27.51	58.56	63.58	98.97	84.26	81.85	75.95	69.65
EBIT to Interest Expense	96.81	95.43	48.21	28.06	37.38	40.88	43.79	35.88	59.84	83.33	86.24	80.16	84.44	74.75	80.21
Interest Expense	3	4	10	17	17	19	23	30	21	16	18	19	18	20	20
Common Equity/Total Assets	67.55	66.59	56.99	62.2	61.71	58.07	52.17	58.99	63.94	63.21	68.64	70.02	71.02	76.58	75.47
Long-Term Debt/Equity (%)	11.24	12.8	38.4	27.29	23.85	31.4	14.83	18.91	15.75	14.6	11.39	11.47	9.86	6.72	6.59
Long-Term Debt/Capital (%)	10.11	11.34	27.75	21.44	19.25	23.9	10.98	15.9	13.53	12.67	10.19	10.25	8.94	6.29	6.17
Long-Term Debt/Total Assets (%)	7.59	8.52	21.89	16.98	14.72	18.23	7.74	11.15	10.07	9.23	7.82	8.03	7.07	5.18	4.97
Total Debt/Equity (%)	11.24	12.8	38.4	27.29	23.85	31.4	35.06	18.91	16.36	15.19	11.83	11.91	10.2	6.96	6.82
Total Debt/Capital (%)	10.11	11.34	27.75	21.44	19.25	23.9	25.96	15.9	14.06	13.19	10.58	10.64	9.25	6.5	6.39
Total Debt/Total Assets (%)	7.59	8.52	21.89	16.98	14.72	18.23	18.29	11.15	10.46	9.6	8.12	8.34	7.32	5.36	5.15
Net Debt to Equity	-1.55	-8.22	11.18	-2.54	-4.85	-4.12	7.38	-3.83	-14.09	-12.86	-4.58	-2.97	-7.97	-24.32	-22.63
Net Debt/Capital (%)	-1.58	-8.96	10.06	-2.61	-5.1	-4.29	6.87	-3.98	-16.03	-14.4	-4.72	-3.01	-8.53	-31.71	-28.87
EBITDA	337	443	581	1,230	702	822	1,171	826	1,236	1,005	1,825	1,638	1,454	1,534	1,421
EBITDA-CapEx	329	436	580	1,219	698	781	1,164	823	1,212	1,005	1,821	1,618	1,441	1,504	1,421
Operating Income (Loss)	300	420	473	483	643	785	1,016	1,073	1,239	1,317	1,587	1,539	1,486	1,480	1,636

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.34	1.5	2.71	3.38	2.57	2.39	0.94	1.09	1.68	1.57	1.42	1.19	1.37	2.64	2.33
Current Ratio	3.49	3.72	4.99	5.24	4.3	4.21	1.8	2.61	3.31	3.46	3.08	3.03	3.38	4.18	3.72
Quick Ratio	2.3	2.5	3.66	4.14	3.35	3.17	1.28	1.7	2.34	2.24	2.07	1.87	2.06	3.12	2.83
CFO/Avg Current Liab	0.92	1.06	1.36	2.65	1.22	1.4	1.03	0.81	1.33	1.17	1.8	1.19	0.81	0.4	0.96
Common Equity/Total Assets	67.55	66.59	56.99	62.2	61.71	58.07	52.17	58.99	63.94	63.21	68.64	70.02	71.02	76.58	75.47
Long-Term Debt/Equity (%)	11.24	12.8	38.4	27.29	23.85	31.4	14.83	18.91	15.75	14.6	11.39	11.47	9.86	6.72	6.59
Long-Term Debt/Capital (%)	10.11	11.34	27.75	21.44	19.25	23.9	10.98	15.9	13.53	12.67	10.19	10.25	8.94	6.29	6.17
Long-Term Debt/Total Assets (%)	7.59	8.52	21.89	16.98	14.72	18.23	7.74	11.15	10.07	9.23	7.82	8.03	7.07	5.18	4.97
Total Debt/Equity (%)	11.24	12.8	38.4	27.29	23.85	31.4	35.06	18.91	16.36	15.19	11.83	11.91	10.2	6.96	6.82
Total Debt/Capital (%)	10.11	11.34	27.75	21.44	19.25	23.9	25.96	15.9	14.06	13.19	10.58	10.64	9.25	6.5	6.39
Total Debt/Total Assets (%)	7.59	8.52	21.89	16.98	14.72	18.23	18.29	11.15	10.46	9.6	8.12	8.34	7.32	5.36	5.15
CFO/Total Liabilities	47.96	48.79	40.56	76.77	35.39	37.25	36.92	42.44	50.56	39.59	64.95	49.01	33.88	18.12	47.48
CFO/CapEx	40.03	51.73	429.73	94.66	144.66	17.06	135.23	308.9	49.29	3,514.33	433.03	60.31	67.35	18.08	- -
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.82	21.45	14.33	13.7	12.26	12.4

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	5.98	6.28	6.56	7.87	8.27	8.71	8.54	8.31	8.69	8.29	9.54	7.29	7.08	7.88	9.57
Days Sales Outstanding	61	58.11	55.64	46.39	44.16	41.93	42.72	43.9	41.99	44.03	38.25	50.09	51.53	46.32	38.16
Inventory Turnover	2.11	1.81	1.75	2.07	1.94	2.17	1.84	1.62	1.79	1.5	1.63	0.9	1.1	1.12	1.21
Days Inventory Outstanding	173.22	201.57	208.39	176.69	188.27	168.56	198.39	225.73	204.36	243.74	223.43	404.04	331.84	325.02	302.69
Accounts Payable Turnover	8.26	6.4	8.85	11.51	10.82	10.61	9.67	7.91	7.3	6.59	5.85	4.29	5.18	6.77	6.47
Accounts Payable Turnover Days	44.2	57.07	41.26	31.71	33.75	34.4	37.73	46.13	49.97	55.38	62.37	85.01	70.45	53.88	56.45
Cash Conversion Cycle	190.03	202.61	222.77	191.38	198.68	176.09	203.38	223.5	196.39	232.39	199.31	369.12	312.91	317.46	284.4
Inventory to Cash Days	-112.22	-143.45	-152.76	-130.3	-144.11	-126.63	-155.66	-181.82	-162.37	-199.71	-185.18	-353.95	-280.31	-278.7	-264.53
Inventories	261	281	309	297	340	397	555	607	641	802	727	876	904	1,087	1,126
Raw Materials	52	50	58	67	64	61	101	112	118	137	133	156	196	241	197
Work In Process	67	59	82	59	64	102	121	145	122	140	164	177	196	236	253
Finished Goods	143	173	169	170	212	234	332	351	401	526	430	542	511	609	677
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	56,454	81,698	45,660	45,784	44,130	50,094
- Cash & Cash Equivalents	171	311	420	654	718	930	818	714	1,179	1,183	863	769	1,132	3,045	2,938
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	69	65	- -
+ Total Debt	150	189	593	598	597	822	1,036	594	679	695	690	691	685	700	705
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	55,747	80,921	45,136	44,906	40,918	46,573
Total Capital	1,488	1,669	2,138	2,790	3,100	3,441	3,993	3,734	4,827	5,269	6,526	6,498	7,405	10,763	11,043
Total Debt/Capital (%)	10.11	11.34	27.75	21.44	19.25	23.9	25.96	15.9	14.06	13.19	10.58	10.64	9.25	6.5	6.39
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.01	0.02	0.02	0.02	0.02
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.71	15.47	10.11	8.96	7.52	7.68
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	55.48	44.34	27.56	30.89	26.68	32.78
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	62.11	47.87	30.12	34.31	29.68	36.84
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	52.17	46.28	36.55	49.27	73.05	28.89
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	52.19	46.39	37.16	50	77.18	28.89
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	57,142	82,627	46,853	46,416	44,932	50,534
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	56,434	81,851	46,329	45,538	41,721	47,013
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	89.29	129.66	74.2	74.71	69.52	80.2
TTM Sales	1,679	1,900	2,046	2,323	2,494	2,964	3,435	3,723	4,348	4,386	5,233	4,464	5,010	5,440	6,068
TTM EBITDA	337	443	581	1,230	702	822	1,171	826	1,236	1,005	1,825	1,638	1,454	1,534	1,421
TTM Operating Income	300	420	473	483	643	785	1,016	1,073	1,239	1,317	1,587	1,539	1,486	1,480	1,636
TTM Cash Flow to Firm	311	365	480	1,034	563	719	1,014	955	1,201	1,068	1,748	1,235	911	560	1,612
TTM Free Cash Flow to Firm	303	358	479	1,024	560	678	1,006	952	1,177	1,068	1,744	1,215	898	530	1,612

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	54.21	47.81	39.11	52.6	87.71	31.68
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	62.11	47.87	30.12	34.31	29.68	36.84
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	55,747	80,921	45,136	44,906	40,918	46,573
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	17.7	78.47	68.32	60.63	59.16	65.72
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.71	15.47	10.11	8.96	7.52	7.68
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	55.48	44.34	27.56	30.89	26.68	32.78
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	68.38	54.28	30.53	32.95	10.73	46.99
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	42.65	42.54	39.44	34.04	11.24	41.62
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	68.9	54.71	53.33	40.73	13.74	47.56
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.39	32.54	27.79	26.23	8.47	35.8
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.34	14	7.86	6.88	4.41	4.85
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.7	10.97	10.16	7.11	4.62	4.29
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.44	14.11	13.74	8.51	5.65	4.9
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.42	8.39	7.16	5.48	3.48	3.69
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.39	18.81	10.48	8.97	6.26	6.73
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.47	14.74	13.54	9.26	6.56	5.96
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.53	18.95	18.31	11.08	8.02	6.81
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.6	11.27	9.54	7.14	4.94	5.13
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.84	15.59	10.41	9.22	8.24	8.31
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.01	12.22	13.45	9.53	8.63	7.36
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.93	15.72	18.18	11.4	10.54	8.41
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.51	9.35	9.47	7.34	6.5	6.33
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	53.4	47.11	38.14	51.59	82.63	31.62
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.31	36.92	49.27	53.29	86.53	28.01
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	53.81	47.48	66.62	63.76	105.76	32
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.45	28.24	34.71	41.06	65.2	24.09
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.82	37.47	50.52	54.34	91.85	28.06
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	54.63	48.19	68.32	65.01	112.25	32.06
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.61	28.66	35.6	41.87	69.21	24.13
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.87	12.09	13.1	9.27	7.91	6.73
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.81	15.59	17.75	11.12	9.79	7.77
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.36	9.21	9.19	7.1	5.81	5.71
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	34.34	34.66	35.69	31.93	28.03	28.75
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	55.91	44.69	48.37	38.32	34.73	33.2
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.29	26.41	25.05	24.46	20.61	24.38
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	38.44	37.42	39.01	35.47	31.19	32.31
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	62.58	48.25	52.88	42.56	38.64	37.31
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.52	28.51	27.38	27.17	22.93	27.4
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	90.43	130.91	75.06	76.17	74.97	86.26
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	91.12	131.93	131.12	94.14	95.95	87.3
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	34,507	63,249	58,459	46,421	43,001	40,850
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	56,176	81,561	79,235	55,710	53,267	47,172
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	10,344	48,198	41,033	35,566	31,609	34,641

Shares Outstanding	685	686	656	647	646	635	629	623	627	624	624	608	601	589	581
Diluted Weighted Avg Shares	716	710	683	651	661	653	648	641	637	632	631	624	609	599	586
Basic Weighted Avg Shares	688	689	670	639	647	639	633	628	625	623	623	619	607	598	585
Revenue per Share	2.44	2.76	3.05	3.64	3.86	4.64	5.43	5.93	6.96	7.05	8.39	7.21	8.26	9.1	10.38
EBITDA per Share	0.49	0.64	0.87	1.92	1.09	1.29	1.85	1.32	1.98	1.61	2.93	2.65	2.4	2.57	2.43
Operating Income per Share	0.44	0.61	0.71	0.76	0.99	1.23	1.61	1.71	1.98	2.11	2.55	2.49	2.45	2.48	2.8
Basic EPS, GAAP	0.34	0.42	0.58	1.27	0.77	0.89	0.92	1.15	1.68	1.32	2.41	2.46	2.31	6.98	1.84
Basic EPS from Cont Ops	0.34	0.42	0.58	1.27	0.77	0.89	0.92	1.15	1.68	1.32	2.41	2.14	2.01	2.34	1.81
Diluted EPS, GAAP	0.33	0.41	0.57	1.25	0.75	0.87	0.9	1.13	1.64	1.3	2.38	2.44	2.3	6.97	1.83
Diluted EPS from Cont Ops	0.33	0.41	0.57	1.25	0.75	0.87	0.9	1.13	1.64	1.3	2.38	2.12	2	2.33	1.8
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.45	0.53	0.71	1.6	0.85	1.1	1.58	1.48	1.89	1.69	2.78	1.97	1.48	0.91	2.73
Free Cash Flow per Basic Share	0.44	0.52	0.7	1.58	0.84	1.04	1.57	1.47	1.85	1.69	2.77	1.94	1.45	0.86	2.73
Cash & Equivalents per Share	0.66	0.76	1.43	2.22	1.9	2	2.13	1.54	2.42	2.25	2.35	2	2.72	6.75	7.28
Book Value per Share	1.95	2.16	2.35	3.39	3.87	4.13	4.7	5.04	6.61	7.33	9.35	9.55	11.06	16.99	17.8
Tangible Book Value per Share	1.35	1.5	1.72	2.77	2.58	2.82	2.16	2.7	4.22	4.92	6.96	7.16	8.49	11.97	12.81

Edwards Lifesciences Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)